This brand name is authorized in Netherlands.
The drug LIVOCAB contains one active pharmaceutical ingredient (API):
1
|
UNII
124XMA6YEI - LEVOCABASTINE HYDROCHLORIDE
|
|
Levocabastine is a potent, fast-acting and highly selective histamine H1-antagonist with a sustained duration of action. |
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| R01AC02 | Levocabastine | R Respiratory system → R01 Nasal preparations → R01A Decongestants and other nasal preparations for topical use → R01AC Antiallergic agents, excl. corticosteroids |
| S01GX02 | Levocabastine | S Sensory organs → S01 Ophthalmologicals → S01G Decongestants and antiallergics → S01GX Other antiallergics |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| NL | Z-Index G-Standaard | 13625306, 14296500 |
| NL | Z-Index G-Standaard, PRK | 33790, 34096 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.